JP2019532635A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019532635A5 JP2019532635A5 JP2019515539A JP2019515539A JP2019532635A5 JP 2019532635 A5 JP2019532635 A5 JP 2019532635A5 JP 2019515539 A JP2019515539 A JP 2019515539A JP 2019515539 A JP2019515539 A JP 2019515539A JP 2019532635 A5 JP2019532635 A5 JP 2019532635A5
- Authority
- JP
- Japan
- Prior art keywords
- msc
- ido
- composition
- oncolytic virus
- infected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662396604P | 2016-09-19 | 2016-09-19 | |
| US62/396,604 | 2016-09-19 | ||
| PCT/US2017/052313 WO2018053529A1 (en) | 2016-09-19 | 2017-09-19 | Method of targeting oncolytic viruses to tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019532635A JP2019532635A (ja) | 2019-11-14 |
| JP2019532635A5 true JP2019532635A5 (enExample) | 2020-10-15 |
| JP7358236B2 JP7358236B2 (ja) | 2023-10-10 |
Family
ID=61619005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515539A Active JP7358236B2 (ja) | 2016-09-19 | 2017-09-19 | 腫瘍溶解性ウイルスを腫瘍に標的化する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11607426B2 (enExample) |
| EP (2) | EP4268838B1 (enExample) |
| JP (1) | JP7358236B2 (enExample) |
| CA (1) | CA3037333A1 (enExample) |
| WO (1) | WO2018053529A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019102268A1 (en) | 2017-11-22 | 2019-05-31 | Mesoblast International Sarl | Cellular compositions and methods of treatment i |
| KR20220038485A (ko) * | 2019-08-05 | 2022-03-28 | 메조블라스트 인터내셔널 에스에이알엘 | 바이러스 벡터를 포함하는 세포 조성물 및 치료 방법 |
| KR102233568B1 (ko) * | 2019-12-13 | 2021-03-30 | 주식회사 알바이오 | 항암 바이러스가 도입된 중간엽 줄기세포의 세포 생존능을 향상시키는 방법 |
| CN115996735A (zh) * | 2020-08-10 | 2023-04-21 | 迈索布拉斯特国际有限公司 | 细胞组合物和治疗方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1879573T3 (da) | 2005-05-10 | 2013-02-25 | Incyte Corp | Modulatorer af indolamin 2,3-dioxygenase og fremgangsmåder til anvendelse deraf |
| US8685728B2 (en) * | 2008-01-31 | 2014-04-01 | Rutgers The State University Of New Jersey | Kit containing stem cells and cytokines for use in attenuating immune responses |
| JP2011518841A (ja) | 2008-04-24 | 2011-06-30 | ニューリンク ジェネティクス， インコーポレイテッド | Ｉｄｏ阻害剤 |
| CA3012229C (en) | 2008-07-08 | 2020-11-10 | Incyte Holdings Corporation | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| EP2493862B1 (en) | 2009-10-28 | 2016-10-05 | Newlink Genetics Corporation | Imidazole derivatives as ido inhibitors |
| US8597637B1 (en) | 2010-05-18 | 2013-12-03 | Weidong Zhang | Breast cancer therapy using an engineered respiratory syncytial virus |
| JP6377632B2 (ja) | 2012-12-14 | 2018-08-22 | ラトガース，ザ ステート ユニバーシティ オブ ニュー ジャージー | 幹細胞の免疫制御作用を調節する方法 |
| WO2014160475A1 (en) * | 2013-03-13 | 2014-10-02 | Aboody Karen S | Tropic cell based virotherapy for the treatment of cancer |
| CA2902174A1 (en) | 2013-03-14 | 2014-10-02 | Newlink Genetics Corporation | Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization |
| WO2015089280A1 (en) | 2013-12-11 | 2015-06-18 | The General Hospital Corporation | Stem cell delivered oncolytic herpes simplex virus and methods for treating brain tumors |
-
2017
- 2017-09-19 EP EP23172956.7A patent/EP4268838B1/en active Active
- 2017-09-19 WO PCT/US2017/052313 patent/WO2018053529A1/en not_active Ceased
- 2017-09-19 US US16/330,858 patent/US11607426B2/en active Active
- 2017-09-19 EP EP17851803.1A patent/EP3515462B1/en active Active
- 2017-09-19 JP JP2019515539A patent/JP7358236B2/ja active Active
- 2017-09-19 CA CA3037333A patent/CA3037333A1/en active Pending
-
2023
- 2023-03-20 US US18/186,869 patent/US20230364147A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Merten et al. | Viral vectors for gene therapy and gene modification approaches | |
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| HRP20180282T1 (hr) | Imunoterapija na bazi indoleamin 2, 3-dioksigenaze | |
| WO2019040920A8 (en) | PREPARATION OF THERAPEUTIC EXOSOMES USING MEMBRANE PROTEINS | |
| WO2020028751A3 (en) | Aav variants with enhanced tropism | |
| EA201892648A1 (ru) | Вирусы пичинде с трехсегментным геномом в качестве векторных вакцин | |
| JP2015524462A5 (enExample) | ||
| JP2014530010A5 (enExample) | ||
| EA201990718A1 (ru) | Векторы аденовируса собачьих | |
| JP2022501055A5 (enExample) | ||
| WO2008096831A1 (ja) | 癌の治療剤 | |
| EP3266464A3 (en) | Yeast-based therapeutic for chronic hepatitis b infection | |
| JP2014051497A5 (enExample) | ||
| JP2016535009A5 (enExample) | ||
| JP2014534202A5 (enExample) | ||
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| JP2013507907A5 (enExample) | ||
| JP2011528896A5 (enExample) | ||
| JP2014502156A5 (enExample) | ||
| MX2020000221A (es) | Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas. | |
| JP2016531927A5 (enExample) | ||
| IN2015DN02546A (enExample) | ||
| EA201690016A1 (ru) | Новый метод иммунотерапии нескольких видов опухолей, таких как рак легкого, включая нмрл | |
| WO2016100328A8 (en) | Novel tilapia virus and uses thereof | |
| JP2011528897A5 (enExample) |